Dextroamphetamine Adipate
Generic Name: dextroamphetamine adipate
Manufactured by TEVA. Dosage form: CAPSULE. Route: ORAL. Active ingredients: AMPHETAMINE ADIPATE (3.75MG); AMPHETAMINE SULFATE (3.75MG); DEXTROAMPHETAMINE ADIPATE (3.75MG); DEXTROAMPHETAMINE SULFATE (3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: ANDA083564.
Overview
Manufactured by TEVA. Dosage form: CAPSULE. Route: ORAL. Active ingredients: AMPHETAMINE ADIPATE (3.75MG); AMPHETAMINE SULFATE (3.75MG); DEXTROAMPHETAMINE ADIPATE (3.75MG); DEXTROAMPHETAMINE SULFATE (3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: ANDA083564.
Dosage
Available as capsule for oral use.
Related Medications
Bouteloua Spp.
bouteloua spp.
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: BOUTELOUA GRACILIS POLLEN (.05 g/mL). Category: BLA.
Epstein-barr Virus Nosode
epstein-barr virus nosode
PURPOSE: Epstein-Barr Virus Nosode - Exhaustion, Mucus Congestion, Fatigue
Lemborexant
lemborexant
Orexin Receptor Antagonist [EPC]
11 DESCRIPTION DAYVIGO contains lemborexant, an orexin receptor antagonist. The chemical name of lemborexant is (1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)- N -(5-fluoropyridin-2-yl) cyclopropanecarboxamide. The molecular formula is C 22 H 20 F 2 N 4 O 2 . The molecular weight is 410.42. The structural formula is: Lemborexant is a white to off-white powder that is practically insoluble in water. DAYVIGO tablets are intended for oral administration.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.